Olimersen

oblimersen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Olimersen, covering 2013-02-21 to 2013-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer [Phase 1, Phase 2]